drugset / Trial / NCT03693599

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

NCT03693599

Phase 4 Completed 1200 enrolled Cairo University
RandomizedParallel-groupDouble-blindPrevention

Summary

to compare effectiveness and tolerability of carbetocin versus syntometrine in prevention of Postpartum hemorrhage after cesarean section

Timeline

Start
2018-10-01
Primary completion
2019-09-15
Completion
2019-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug Intravenous
Comparator Oxytocin Peptide 5 iu Intravenous
Comparator ergometrine Unknown 500 ug Intravenous

Indications

No indication recorded.